Cellcept

Cellcept (Mycophenolate Mofetil) is an oral medication used to prevent organ rejection after transplants. It works by suppressing the immune system to help the body accept the new organ.

Cellcept is primarily used to prevent rejection in patients who have received a kidney, heart, or liver transplant. It belongs to a class of drugs known as immunosuppressants, which work by reducing the activity of the immune system. This helps the body accept the transplanted organ without attacking it as a foreign object. Cellcept is often prescribed in combination with other medications to enhance its effectiveness.

Common effects of Cellcept may include nausea, vomiting, diarrhea, and abdominal pain. Some users might also experience fatigue, headache, or an increased risk of infections due to its immune-suppressing properties. It is important to monitor for any signs of infection or unusual bleeding while taking this medication.

Cellcept should be handled with care, as it can increase the risk of infections and other serious side effects. It is important to follow the prescribed dosage and not to stop taking the medication without consulting a healthcare provider. Pregnant women or those planning to become pregnant should discuss the risks with their doctor, as Cellcept can cause birth defects.

Cellcept may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol should be avoided while taking Cellcept, as it can increase the risk of side effects.